A SPAC III net loss narrows to $15,218 in Q2 FY26 from profit a year earlier

A SPAC III Acquisition posted a GAAP net loss of $15,218 for the quarter ended June 30, 2026, swinging from net income of $379,939 a year earlier.

Interest income fell to $31,977 from $646,975, while legal and professional expenses dropped to $7,788 from $208,172.

Nasdaq granted an extension to Nov. 12, 2026 to regain compliance with its $2.5 million stockholders’ equity rule, tied to the proposed Bioserica deal.

For the six months, GAAP net loss widened to $129,206, reversing from net income of $793,141 a year earlier.

Cash on hand totaled $633,724, with working capital of $237,744; marketable securities in the trust account were $3.03 million.